Company
Headquarters: Taichung, Taiwan
TW$3.94 Billion
TWD as of Jan. 1, 2026
US$125.6 Million
| Company | Market Cap (USD) |
|---|---|
| Intuitive | $201.46 B |
| EssilorLuxottica SA | $144.43 B |
| Becton, Dickinson and Company | $55.63 B |
| HOYA Corp | $50.63 B |
| Alcon Inc. | $39.46 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $968.50 B |
| Johnson & Johnson | $499.57 B |
| AbbVie | $405.28 B |
| Roche | $332.12 B |
| UnitedHealth Group | $304.72 B |
Bionime Corporation manufactures and sells medical instruments in Algeria, the United States, Switzerland, China, and internationally. It offers medical testing blood glucose management products for self-monitor and hospital/clinic use, as well as accessories, such as test strips and lancing devices. The company was founded in 2003 and is headquartered in Taichung, Taiwan.
Bionime Corp has the following listings and related stock indices.
Stock: TWSE: 4737